ArticleVirology journal2023

Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison.

Inge Kroidl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.